Comparative Effectiveness Research of Disease-Modifying Therapies for the Management of Multiple Sclerosis: Analysis of a Large Health Insurance Claims Database-Reference-Cited by-同舟云学术

Comparative Effectiveness Research of Disease-Modifying Therapies for the Management of Multiple Sclerosis: Analysis of a Large Health Insurance Claims Database

Published:2017-02-16 Issue:1 Volume:6 Page:91-102
ISSN:2193-8253
Container-title:Neurology and Therapy
language:en
Short-container-title:Neurol Ther

Author:

Boster Aaron,Nicholas Jacqueline,Wu Ning,Yeh Wei-Shi,Fay Monica,Edwards Michael,Huang Ming-Yi,Lee Andrew

Funder

Biogen

Publisher

Springer Science and Business Media LLC

Subject

Neurology (clinical),Neurology

Link

http://link.springer.com/content/pdf/10.1007/s40120-017-0064-x.pdf

Reference28 articles.

1. Goldenberg MM. Multiple sclerosis review. P T. 2012;37(3):175–84.

2. Compston A, Coles A. Multiple sclerosis. Lancet. 2008;372(9648):1502–17.

3. Kantarci OH, Pirko I, Rodriguez M. Novel immunomodulatory approaches for the management of multiple sclerosis. Clin Pharmacol Ther. 2014;95(1):32–44.

4. Campbell JD, Ghushchyan V, Brett McQueen R, et al. Burden of multiple sclerosis on direct, indirect costs and quality of life: National US estimates. Mult Scler Relat Disord. 2014;3(2):227–36.

5. Browne P, Chandraratna D, Angood C, et al. Atlas of multiple sclerosis 2013: a growing global problem with widespread inequity. Neurology. 2014;83(1):1022–4.

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative efficacy of diroximel fumarate, ozanimod and interferon beta-1a for relapsing multiple sclerosis using matching-adjusted indirect comparisons;Journal of Comparative Effectiveness Research;2024-08-19

2. Clinical effectiveness of dimethyl fumarate in multiple sclerosis patients from Argentina;Neurological Sciences;2024-07-31

3. Escalating to medium‐ versus high‐efficacy disease modifying therapy after low‐efficacy treatment in relapsing remitting multiple sclerosis;Brain and Behavior;2024-04-30

4. The Efficacy of Fingolimod and Interferons in Controlling Disability and Relapse Rate in Patients with Multiple Sclerosis: A Systematic Review and Meta-Analysis;International Journal of Preventive Medicine;2023-12

5. Real-world treatment patterns and effectiveness of cladribine tablets in patients with relapsing forms of multiple sclerosis in the United States;Multiple Sclerosis and Related Disorders;2023-11